Yucel, K. and Azak, H. 2024. Identifying highly effective fludarabine-based novel target cancer therapy agents by in silico studies. EXPERIMENTAL BIOMEDICAL RESEARCH. 7, 2 (Mar. 2024), 84–93. DOI:https://doi.org/10.30714/j-ebr.2024.211.